Cancer Physician/Scientist Leader, Huntsman Cancer Institute Genitourinary Cancers Center Professor of Radiation Oncology

Salt Lake City, UT
Joined November 2011
Jonathan Tward retweeted
New in #practicalRO: Intrafraction Motion Mitigation by Rectal Spacers in Prostate SBRT: Balloon, Hydrogel, and No-Spacer Comparison. tinyurl.com/probvtward
1
8
15
1,631
I almost never post things. However, this was worth the time. Obviously level 1 evidence has been the highest standard, but some prospective studies are garbage design and some retrospectives ones are exceptional. Quality of evidence and level are distinct
Some doctors publish level 3-4 evidence, and the other doctors in their specialty celebrate it. Radiation oncologists publish level 1-2 evidence, and other radiation oncologists criticize it.
1
3
1,139
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI @US_FDA and dedicated my career to help men and their families suffering from PCa @nytimes @WSJ @FoxNews @CNN @NBCNews @Reuters @ASCO @PCFnews @DeptofDefense
28
144
19
363
95,117
Tweetorial on our recently published paper in @NEJMEvidence on the development and validation of the 1st predictive biomarker to guide ADT use in prostate cancer. Enjoy! #PCSM @arteraAI @NRGonc @felixfengmd @DrHowardSandler @EdwardSchaeffer @prostatemd @AarmstrongDuke
One of the most impactful projects I have been fortunate to be part of with many incredible collaborators, @felixfengmd , @NRGonc , @arteraAI all coming together to create the 1st validated predictive biomarker for ADT use in PCa. Big win for patients! @uhradonc @caseccc #PCSM
9
47
5
160
73,838
#ASCO23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert @urotoday @PCFnews
4
89
6
172
40,202
Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 rb.gy/819hr @huntsmancancer @BogdanaSchmidt @ASanchez_UroOnc @prostatemd @sky__john @NeliMUlrich @helops79 @neerajaiims @nsayeghmd @umangtalking @maughanonc @vinay_onc
Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 rb.gy/819hr @huntsmancancer @Huntsman_GU @sky__john @prostatemd
4
4
1,064
Alas! My medical scribes always get into medical school and leave me 😉. If you know a smart college grad who would like to work as my scribe/research assistant for at least 1 year @huntsmancancer . Please encourage them to apply: tinyurl.com/y58yy9sj
1
1
3
388
Have a blast, and support men with prostate cancer! @Huntsman_GU @huntsmancancer
3
6
1,721
Jonathan Tward retweeted
Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 #ProstateCancer. Presented by @prostatemd @huntsmancancer. @ASCO #GU23 written coverage by @tchandra_uromd @JEFFUrology > bit.ly/3S6AI2M
1
1
706
Jonathan Tward retweeted
Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic #ProstateCancer to bone. Presentation by @prostatemd @huntsmancancer. @ASCO #GU23 coverage by @WallisCJD > bit.ly/3lK8LBJ
2
1
664
Twitterverse Poll: The ongoing healthcare financial crisis and workforce challenges will lead over 5 yrs…: Comment other ideas! I would appreciate if you reply and retweet to get a broad perspective. @seanmmcbride @subatomicdoc @VPrasadMDMPH @EricTopol @ASCO @ASTRO_org – at Beachwood, OH
34%Contraction to⬇️ sites
20%Socialized heathcare
24%Virtual care outsourcing
22%Government bailouts
146 votes • Final results
5
7
1
8
Jonathan Tward retweeted
#ProstateCancer risk stratification in @NRGOncology phase III randomized trials using multi-modal deep learning with digital histopathology. Presentation by @prostatemd @huntsmancancer. #ASTRO22 written coverage by @rksayyid @UofT on UroToday > bit.ly/3TZbBzn @ASTRO_org
3
11
When looking at absolute benefit you can see how we likely need to move away from just STADT for intermediate risk and LTADT for high risk. Amazing data to personalize tx and ADT duration for pts. @prostatemd @NicholasZaorsky @HimanshuNagarMD @rtdess @RadOncDocJ @SouMyajiT_RO
1
11
1
24
Interested in #radonc @huntsmancancer @UofUHealth? Join our residents for meet & greets on 9/16 or 10/7 #match2023 Sign up here: docs.google.com/spreadsheets…
I study alternative treatments, cancer misinformation and I also treat prostate cancer so hopefully, I can provide some insights. After some searching, there are some MAJOR red flags. Here is what I found: TLDR: Side-effect-free chemo should be renamed evidence-free chemo 🧵
William Hurt had metastatic prostate cancer. According to reports, he was treated with a regimen called "Side Effect Free Chemo," by a Dr. Kenneth Matsumura which apparently has minimal evidence. Does anyone know more about this? Frankly, I find this highly suspicious.
4
23
4
69
Jonathan Tward retweeted
Happy to share our predictive nomograms for patients with pathologically node positive prostate cancer #radonc #pcsm @prostatemd @UofURadOnc @huntsmancancer clinical-genitourinary-cance…
1
3
14